BRPI0407400A - derivados do ácido 10,10-dialquil prostanóico como agentes para o abaixamento de pressão intra-ocular - Google Patents

derivados do ácido 10,10-dialquil prostanóico como agentes para o abaixamento de pressão intra-ocular

Info

Publication number
BRPI0407400A
BRPI0407400A BRPI0407400-9A BRPI0407400A BRPI0407400A BR PI0407400 A BRPI0407400 A BR PI0407400A BR PI0407400 A BRPI0407400 A BR PI0407400A BR PI0407400 A BRPI0407400 A BR PI0407400A
Authority
BR
Brazil
Prior art keywords
agents
intraocular pressure
prostanoic acid
acid derivatives
glaucoma
Prior art date
Application number
BRPI0407400-9A
Other languages
English (en)
Inventor
Yavi Donde
Jeremiah H Nguyen
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/365,369 external-priority patent/US6875787B2/en
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0407400A publication Critical patent/BRPI0407400A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/08Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"DERIVADOS DO áCIDO 10,10-DIALQUIL PROSTANóICO COMO AGENTES PARA O ABAIXAMENTO DA PRESSãO INTRAOCULAR". A presente invenção proporciona um método para o tratamento da hipertensão ocular ou glaucoma, que compreende a administração a um animal que tenha hipertensão ocular ou glaucoma, de uma quantidade terapeuticamente eficaz de um composto representado pela fórmula geral (I), na qual a linha pontilhada indica a presença ou a ausência de uma ligação, a borda interrompida indica a configuração a (para baixo) e o triângulo sólido indica a configuração <225> (para cima); B é uma ligação covalente simples, dupla ou tripla; n é 0 a 6; X é CH~ 2~, S OU O; Y é qualquer sal farmaceuticamente aceitável de CO~ 2~H ou CO~ 2~R, CONR~ 2~, CONHCH~ 2~CH~ 2~OH, CON(CH~ 2~CH~ 2~OH)~ 2~, CH~ 2~OR, P(O)(OR)~ 2~, CONRSO~ 2~R, SONR~ 2~, ou a fórmula (Ia) na qual R é H, C~ 1-6~ alquila ou C~ 2-6~ alquenila; R¬ 2¬ e R¬ 3¬ são C~ 1-6~ alquila linear que podem ser o mesmo ou diferentes, e podem estar ligados um com o outro de tal forma que eles formem um anel que incorpora o carbono ao qual eles estão ligados comumente.
BRPI0407400-9A 2003-02-11 2004-02-06 derivados do ácido 10,10-dialquil prostanóico como agentes para o abaixamento de pressão intra-ocular BRPI0407400A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/365,369 US6875787B2 (en) 2003-02-11 2003-02-11 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
US10/772,720 US20040235958A1 (en) 2003-02-11 2004-02-04 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
PCT/US2004/003433 WO2004071428A2 (en) 2003-02-11 2004-02-06 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure

Publications (1)

Publication Number Publication Date
BRPI0407400A true BRPI0407400A (pt) 2006-02-21

Family

ID=32871611

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407400-9A BRPI0407400A (pt) 2003-02-11 2004-02-06 derivados do ácido 10,10-dialquil prostanóico como agentes para o abaixamento de pressão intra-ocular

Country Status (12)

Country Link
EP (1) EP1608309B1 (pt)
JP (1) JP5319065B2 (pt)
KR (1) KR101077461B1 (pt)
AU (1) AU2004211936B2 (pt)
BR (1) BRPI0407400A (pt)
CA (1) CA2515631C (pt)
MX (1) MXPA05008431A (pt)
NO (1) NO334659B1 (pt)
NZ (1) NZ541352A (pt)
PL (1) PL209130B1 (pt)
RU (1) RU2336081C2 (pt)
WO (1) WO2004071428A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7855226B2 (en) 2003-02-11 2010-12-21 Allergan, Inc. Treatment of inflammatory bowel disease
CA2585367A1 (en) * 2004-10-26 2006-05-04 Allergan, Inc. Therapeutic and delivery methods of prostaglandin ep4 agonists
AU2012200514B2 (en) * 2005-03-17 2014-03-06 Allergan, Inc. Treatment of inflammatory bowel disease
PL2084124T3 (pl) * 2006-10-02 2014-08-29 Techfields Biochem Co Ltd Dodatnio naładowane rozpuszczalne w wodzie proleki prostaglandyn i związków pokrewnych o bardzo dużych szybkościach przenikania przez skórę
CN105566192B (zh) * 2006-10-02 2019-01-22 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的前列腺素及相关化合物的前药
US8455547B2 (en) * 2008-02-05 2013-06-04 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US7732443B2 (en) * 2008-03-18 2010-06-08 Yariv Donde Therapeutic substituted cyclopentanes
WO2009137345A1 (en) * 2008-05-09 2009-11-12 Allergan, Inc. Therapeutic compounds
EP2488168A1 (en) 2009-10-14 2012-08-22 Gemmus Pharma Inc. Combination therapy treatment for viral infections
CN103068382A (zh) * 2010-07-30 2013-04-24 阿勒根公司 用于皮肤修复的化合物和方法
SG187861A1 (en) * 2010-08-17 2013-03-28 Allergan Inc Ep2 or ep4 agonists for treating corneal haze
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117014A (en) 1976-01-09 1978-09-26 Abbott Laboratories Prostaglandin derivatives
JPS59101458A (ja) * 1982-12-01 1984-06-12 Nippon Iyakuhin Kogyo Kk 新規なチアプロスタグランジン誘導体及びその製法
JPS632972A (ja) * 1986-06-20 1988-01-07 Nippon Iyakuhin Kogyo Kk 新規プロスタグランジンe↓1誘導体及びその製法
US5462968A (en) * 1994-01-19 1995-10-31 Allergan, Inc. EP2 -receptor agonists as agents for lowering intraocular pressure
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
US6410591B1 (en) * 2001-05-08 2002-06-25 Allergan Sales, Inc. 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
AU2002259210B2 (en) * 2001-06-14 2007-11-08 Allergan, Inc. 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
PL378421A1 (pl) 2006-04-03
NO334659B1 (no) 2014-05-12
AU2004211936A1 (en) 2004-08-26
RU2005129072A (ru) 2006-02-27
CA2515631A1 (en) 2004-08-26
EP1608309B1 (en) 2012-07-11
JP5319065B2 (ja) 2013-10-16
WO2004071428A3 (en) 2005-11-10
PL209130B1 (pl) 2011-07-29
JP2006517587A (ja) 2006-07-27
RU2336081C2 (ru) 2008-10-20
AU2004211936B2 (en) 2008-09-11
NO20053715D0 (no) 2005-08-01
EP1608309A2 (en) 2005-12-28
NZ541352A (en) 2007-12-21
KR20050101202A (ko) 2005-10-20
CA2515631C (en) 2013-08-20
WO2004071428A2 (en) 2004-08-26
NO20053715L (no) 2005-10-27
KR101077461B1 (ko) 2011-10-26
MXPA05008431A (es) 2005-10-19

Similar Documents

Publication Publication Date Title
BR0310047A (pt) Análogos de 8-azaprostaglandina como agentes para diminuição de pressão intra-ocular
BRPI0407400A (pt) derivados do ácido 10,10-dialquil prostanóico como agentes para o abaixamento de pressão intra-ocular
CY1110969T1 (el) 5-υποκατεστημενα-2-φαινυλαμινο-βενζαμιδια ως αναστολεiς μεκ
TW200420549A (en) Thiazole derivatives
UY28132A1 (es) Derivados de pirrolopirimidina
MX2008002061A (es) Derivados de tiazolil piperidina utiles como moduladores del receptor h3.
WO2007095174A3 (en) Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions
CY1113138T1 (el) Παραγωγα 10,10-διαλκυλ προστανοϊκου οξεος ως παραγοντες για μειωση ενδο-οφθαλμικης πιεσης
RS20080533A (en) Triazolopyrazine derivatives useful as anticancer agents
ATE517882T1 (de) Chinolinderivate
UA94606C2 (ru) Производные тиоксантина, композиция, которая их содержит, и их применение в терапии
UA95766C2 (ru) Производные терфенила для лечения болезни альцгеймера
EA200800303A1 (ru) Применение производных и аналогов тиазола при нарушениях, вызванных свободными жирными кислотами
TW200700069A (en) Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives
DOP2005000039A (es) Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
EA200700901A1 (ru) Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии
TW200716547A (en) Piperidin-4-yl-amide derivatives
TW200740827A (en) Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
PE20070120A1 (es) Derivados de prostaglandina
BR0314352A (pt) Indóis 2,7-substituìdos e seu uso como moduladores de 5-ht6
ATE492534T1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
AR002018A1 (es) Derivado de benzotiepina opticamente activo; metodo para producirlo; compuesto opticamente activo de uso en dicho metodo; promotor deosteogenesis, agente para prevenir o tratar enfermedades del hueso, promotor para el tratamiento de la fractura de hueso, metodo de tratamiento y
AR014964A1 (es) Derivados de indol, composiciones farmaceuticas que los contienen, agentes para reducir la presion intraocular, tratar glaucoma e hipertension ocular, usosen la fabricacion de composiciones farmaceuticas y procedimiento de fabricacion de dichas composiciones
BR0312798A (pt) Derivados de isotiazol úteis como agentes anticancerìgenos
AR050043A1 (es) Metodos para mejorar la biodisponibilidad y composicion farmaceutica para trastornos cardiovasculares

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 11, 13, 22 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]